Back to trial details

Intake questionnaire

Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer

Applying to Emory University Hospital Midtown · Atlanta, Georgia

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Advanced Lung Adenocarcinoma?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Atlanta for study visits?